TW239077B - - Google Patents
Info
- Publication number
- TW239077B TW239077B TW082109174A TW82109174A TW239077B TW 239077 B TW239077 B TW 239077B TW 082109174 A TW082109174 A TW 082109174A TW 82109174 A TW82109174 A TW 82109174A TW 239077 B TW239077 B TW 239077B
- Authority
- TW
- Taiwan
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7144093A | 1993-06-02 | 1993-06-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW239077B true TW239077B (es) | 1995-01-21 |
Family
ID=22101339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW082109174A TW239077B (es) | 1993-06-02 | 1993-11-03 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0701439A1 (es) |
| JP (1) | JPH08511006A (es) |
| AU (1) | AU7051794A (es) |
| CA (1) | CA2163640A1 (es) |
| OA (1) | OA10198A (es) |
| TW (1) | TW239077B (es) |
| WO (1) | WO1994027594A2 (es) |
| ZA (1) | ZA943857B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6562854B2 (en) | 1994-12-14 | 2003-05-13 | Axys Pharmaceuticals, Inc. | Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders |
| WO1996039144A1 (en) * | 1995-06-06 | 1996-12-12 | Procyte Corporation | Stable copper(i) complexes as active therapeutic substances |
| US5637311A (en) * | 1995-06-29 | 1997-06-10 | Procyte Corporation | Zinc(II) complexes and methods related thereto |
| US7045531B1 (en) | 1997-03-11 | 2006-05-16 | The General Hospital Corporation | Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator |
| US6150379A (en) * | 1997-11-26 | 2000-11-21 | Axys Pharmaceuticals, Inc. | Compounds and compositions as anticoagulants |
| US6638711B1 (en) | 1999-04-29 | 2003-10-28 | The General Hospital Corporation | Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation |
| WO2005115379A2 (en) * | 2004-05-24 | 2005-12-08 | New York University | Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux |
| BRPI0613824A2 (pt) * | 2005-06-20 | 2011-02-15 | Dynamiclear Pty Ltd | composição para tratamento de lesões da pele |
| WO2010026730A1 (ja) * | 2008-09-03 | 2010-03-11 | Nbc株式会社 | 抗ウイルス剤 |
| US10098857B2 (en) | 2008-10-10 | 2018-10-16 | The Board Of Trustees Of The Leland Stanford Junior University | Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds |
| TWI580787B (zh) * | 2012-12-28 | 2017-05-01 | 簡宏堅 | 重組蛋白質、含有該重組蛋白質之醫藥組成物及該重組蛋白質之製備方法 |
| WO2019055490A1 (en) | 2017-09-14 | 2019-03-21 | The Board Of Trustees Of The Leland Stanford Junior University | PACKAGING OF IRRADIED FABRIC FOR FAT GREETING RETENTION |
| EP3810144A4 (en) * | 2018-06-04 | 2022-08-17 | Chemistryrx | TOPICAL HAIR GROWTH STIMULATING COMPOSITIONS |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4760051A (en) * | 1985-01-24 | 1988-07-26 | Pickart Loren R | Use of GHL-Cu as a wound-healing and anti-inflammatory agent |
| JPS6259213A (ja) * | 1985-09-10 | 1987-03-14 | Eisai Co Ltd | ス−パ−オキサイド除去剤 |
-
1993
- 1993-11-03 TW TW082109174A patent/TW239077B/zh active
-
1994
- 1994-06-02 WO PCT/US1994/006247 patent/WO1994027594A2/en not_active Application Discontinuation
- 1994-06-02 CA CA002163640A patent/CA2163640A1/en not_active Abandoned
- 1994-06-02 ZA ZA943857A patent/ZA943857B/xx unknown
- 1994-06-02 EP EP94919342A patent/EP0701439A1/en not_active Withdrawn
- 1994-06-02 JP JP7501073A patent/JPH08511006A/ja active Pending
- 1994-06-02 AU AU70517/94A patent/AU7051794A/en not_active Abandoned
-
1995
- 1995-12-01 OA OA60750A patent/OA10198A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| OA10198A (en) | 1996-12-18 |
| AU7051794A (en) | 1994-12-20 |
| WO1994027594A2 (en) | 1994-12-08 |
| WO1994027594A3 (en) | 1995-04-27 |
| JPH08511006A (ja) | 1996-11-19 |
| EP0701439A1 (en) | 1996-03-20 |
| CA2163640A1 (en) | 1994-12-08 |
| ZA943857B (en) | 1995-02-01 |